LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.29 Cr | ₹3.83 Cr | ₹4.01 Cr | ₹4.23 Cr | ₹-16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LYKA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹4.29 Cr |
| Mar2024 | ₹3.83 Cr |
| Mar2023 | ₹4.01 Cr |
| Mar2022 | ₹4.23 Cr |
| Mar2021 | ₹-16 Cr |
How is Deferred Tax Assets / Liabilities of LYKA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.29 Cr | 12.15 | |
| Mar2024 | ₹3.83 Cr | -4.54 | |
| Mar2023 | ₹4.01 Cr | -5.27 | |
| Mar2022 | ₹4.23 Cr | Positive | |
| Mar2021 | ₹-16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹246.3 Cr | -2.8% | -3.3% | -37.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -2.8% |
-3.3% |
-37.7% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses